SEC Form 4 · accession 0001179110-18-002032
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
Jan 22, 2018
Accepted (ET)
Feb 13, 2018 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2018 | M | 18,460 | $6.01 | A | 36,867 | D | |
| Common Stock | Jan 22, 2018 | M | 2,286 | $6.01 | A | 39,153 | D | |
| Common Stock | Feb 9, 2018 | M | 25,834 | $6.01 | A | 64,987 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.01 | Jan 22, 2018 | M | 18,460 | D | — | Sep 10, 2024 | Common Stock | 18,460 | 13,670 | D |
| Employee Stock OptionF2 | $6.01 | Jan 22, 2018 | M | 2,286 | D | — | Dec 22, 2024 | Common Stock | 2,286 | 107,368 | D |
| Employee Stock Option (right to buy)F2 | $6.01 | Feb 9, 2018 | M | 25,834 | D | — | Dec 22, 2024 | Common Stock | 25,834 | 81,534 | D |
Explanation of responses
- F1The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F2The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.